These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 23189874)

  • 21. Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial.
    Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) investigators
    Lancet; 2006 Feb; 367(9510):569-78. PubMed ID: 16488800
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and efficacy of tenecteplase in acute myocardial infarction.
    Guerra DR; Karha J; Gibson CM
    Expert Opin Pharmacother; 2003 May; 4(5):791-8. PubMed ID: 12740001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of tenecteplase in Indian patients with ST-segment elevation myocardial infraction: a future perspetive.
    Tewari S
    Indian Heart J; 2008; 60(6):504-6. PubMed ID: 19276486
    [No Abstract]   [Full Text] [Related]  

  • 24. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction.
    Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 Investigators
    Lancet; 2001 Aug; 358(9282):605-13. PubMed ID: 11530146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [An angiographic trial to evaluate the efficacy and safety of tenecteplase in Chinese patients with acute myocardial infarction].
    Liang F; Wang LZ; Hu DY; Shi XB; Wei JP; Zhao H; Wang L; Jia SQ; Wang HY; Liu RH; Chen YD; Lu YL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Jun; 37(6):514-7. PubMed ID: 19927632
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Erythropoietin to augment myocardial salvage induced by coronary thrombolysis in patients with ST segment elevation acute myocardial infarction.
    Binbrek AS; Rao NS; Al Khaja N; Assaqqaf J; Sobel BE
    Am J Cardiol; 2009 Oct; 104(8):1035-40. PubMed ID: 19801020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bolus fibrinolytic therapy in acute myocardial infarction.
    Llevadot J; Giugliano RP; Antman EM
    JAMA; 2001 Jul; 286(4):442-9. PubMed ID: 11466123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tenecteplase: new preparation. Another thrombolytic agent for myocardial infarction: a slightly simpler treatment.
    Prescrire Int; 2002 Jun; 11(59):83-4. PubMed ID: 12068843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The safety and efficacy of systemic salvage thrombolysis in acute myocardial infarct].
    Sarullo FM; Schicchi R; Schirò M; Americo L; Bonnì G; Faraone N; Di Pasquale P; Castello A; Mauri F
    Ital Heart J Suppl; 2000 Jan; 1(1):81-7. PubMed ID: 10832123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ST-segment-elevation myocardial infarction patients randomized to a pharmaco-invasive strategy or primary percutaneous coronary intervention: Strategic Reperfusion Early After Myocardial Infarction (STREAM) 1-year mortality follow-up.
    Sinnaeve PR; Armstrong PW; Gershlick AH; Goldstein P; Wilcox R; Lambert Y; Danays T; Soulat L; Halvorsen S; Ortiz FR; Vandenberghe K; Regelin A; Bluhmki E; Bogaerts K; Van de Werf F;
    Circulation; 2014 Sep; 130(14):1139-45. PubMed ID: 25161043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of pre-hospital thrombolytic treatment on re-infarction rates: analysis of the Myocardial Infarction National Audit Project (MINAP).
    Horne S; Weston C; Quinn T; Hicks A; Walker L; Chen R; Birkhead J
    Heart; 2009 Apr; 95(7):559-63. PubMed ID: 17923462
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ischemic stroke complicating thrombolytic therapy with tenecteplase for ST elevation myocardial infarction: two case reports.
    Arous S; Haboub M; El Ghali Benouna M; Bentaoune T; Habbal R
    J Med Case Rep; 2017 Jun; 11(1):154. PubMed ID: 28601092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intravenous NPA for the treatment of infarcting myocardium early; InTIME-II, a double-blind comparison of single-bolus lanoteplase vs accelerated alteplase for the treatment of patients with acute myocardial infarction.
    InTIME-II Investigators
    Eur Heart J; 2000 Dec; 21(24):2005-13. PubMed ID: 11102251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracoronary thrombolysis in patients with ST-segment elevation myocardial infarction presenting with massive intraluminal thrombus and failed aspiration.
    Boscarelli D; Vaquerizo B; Miranda-Guardiola F; Arzamendi D; Tizon H; Sierra G; Delgado G; Fantuzzi A; Estrada D; Garcia-Picart J; Cinca J; Serra A
    Eur Heart J Acute Cardiovasc Care; 2014 Sep; 3(3):229-36. PubMed ID: 24637066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bolus tenecteplase for right ventricle dysfunction in hemodynamically stable patients with pulmonary embolism.
    Becattini C; Agnelli G; Salvi A; Grifoni S; Pancaldi LG; Enea I; Balsemin F; Campanini M; Ghirarduzzi A; Casazza F;
    Thromb Res; 2010 Mar; 125(3):e82-6. PubMed ID: 19833379
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome of acute ST-segment elevation myocardial infarction in diabetics treated with fibrinolytic or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: lessons from the GUSTO V trial.
    Gurm HS; Lincoff AM; Lee D; Tang WH; Jia G; Booth JE; Califf RM; Ohman EM; Van de Werf F; Armstrong PW; Guetta V; Wilcox R; Topol EJ;
    J Am Coll Cardiol; 2004 Feb; 43(4):542-8. PubMed ID: 14975461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of cardiac care variation on ST-elevation myocardial infarction outcomes in Malaysia.
    Selvarajah S; Fong AY; Selvaraj G; Haniff J; Hairi NN; Bulgiba A; Bots ML
    Am J Cardiol; 2013 May; 111(9):1270-6. PubMed ID: 23415636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of in-hospital mortality in patients with ST-segment elevation myocardial infarction undergoing pharmacoinvasive treatment.
    Falcão FJ; Alves CM; Barbosa AH; Caixeta A; Sousa JM; Souza JA; Amaral A; Wilke LC; Perez FC; Gonçalves Júnior I; Stefanini E; Carvalho AC
    Clinics (Sao Paulo); 2013 Dec; 68(12):1516-20. PubMed ID: 24473509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In-hospital major bleeding during ST-elevation and non-ST-elevation myocardial infarction care: derivation and validation of a model from the ACTION Registry®-GWTG™.
    Mathews R; Peterson ED; Chen AY; Wang TY; Chin CT; Fonarow GC; Cannon CP; Rumsfeld JS; Roe MT; Alexander KP
    Am J Cardiol; 2011 Apr; 107(8):1136-43. PubMed ID: 21324428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tenecteplase for treatment of acute myocardial infarction.
    Turcasso NM; Nappi JM
    Ann Pharmacother; 2001 Oct; 35(10):1233-40. PubMed ID: 11675853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.